Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Raghavendra

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
The Plant Journal : for Cell and Molecular Biology|June 26, 2024
Serine hydroxymethyltransferase6 is involved in growth and resistance against pathogens via ethylene and lignin production in ArabidopsisPooja Singh, Aprajita Kumari, Vemula Chandra Khaladhar, et al.
Nature Communications|June 28, 2017
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancersSmruthi Vijayaraghavan, Cansu Karakas, Iman Doostan, et al.
Journal of Experimental Botany|December 6, 2011
Multiple strategies to prevent oxidative stress in Arabidopsis plants lacking the malate valve enzyme NADP-malate dehydrogenaseInga Hebbelmann, Jennifer Selinski, Corinna Wehmeyer, et al.
Clinical Breast Cancer|August 6, 2018
Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution ExperienceRashmi K Murthy, Akshara S Raghavendra, Kenneth R Hess, et al.
Investigational New Drugs|January 6, 2019
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II studyClinton Yam, Francisco J Esteva, Miral M Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain MetastasesSheheryar Kabraji, Jing Ni, Sarah Sammons, et al.
ESMO Open|November 5, 2024
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆A S Raghavendra, D B Zakon, Q Jin, et al.
ESMO Open|August 29, 2025
Adjuvant capecitabine in patients with triple-negative breast cancer after neoadjuvant chemotherapyA Strahan, Q Jin, A S Raghavendra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2019
Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast CancerNicole M Kettner, Smruthi Vijayaraghavan, Merih Guray Durak, et al.
Multiple Sclerosis and Related Disorders|July 31, 2022
A real world multi center study on efficacy and safety of natalizumab in Indian patients with multiple sclerosisThomas Mathew, Vikram Kamath, Saji K John, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
The Plant Journal : for Cell and Molecular Biology|June 26, 2024
Serine hydroxymethyltransferase6 is involved in growth and resistance against pathogens via ethylene and lignin production in ArabidopsisPooja Singh, Aprajita Kumari, Vemula Chandra Khaladhar, et al.
Nature Communications|June 28, 2017
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancersSmruthi Vijayaraghavan, Cansu Karakas, Iman Doostan, et al.
Journal of Experimental Botany|December 6, 2011
Multiple strategies to prevent oxidative stress in Arabidopsis plants lacking the malate valve enzyme NADP-malate dehydrogenaseInga Hebbelmann, Jennifer Selinski, Corinna Wehmeyer, et al.
Clinical Breast Cancer|August 6, 2018
Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution ExperienceRashmi K Murthy, Akshara S Raghavendra, Kenneth R Hess, et al.
Investigational New Drugs|January 6, 2019
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II studyClinton Yam, Francisco J Esteva, Miral M Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain MetastasesSheheryar Kabraji, Jing Ni, Sarah Sammons, et al.
ESMO Open|November 5, 2024
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆A S Raghavendra, D B Zakon, Q Jin, et al.
ESMO Open|August 29, 2025
Adjuvant capecitabine in patients with triple-negative breast cancer after neoadjuvant chemotherapyA Strahan, Q Jin, A S Raghavendra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2019
Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast CancerNicole M Kettner, Smruthi Vijayaraghavan, Merih Guray Durak, et al.
Multiple Sclerosis and Related Disorders|July 31, 2022
A real world multi center study on efficacy and safety of natalizumab in Indian patients with multiple sclerosisThomas Mathew, Vikram Kamath, Saji K John, et al.
Pageof 18